Onset and progression of chronic disease and disability in a large cohort of older Australian women.


Journal

Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333

Informations de publication

Date de publication:
04 2022
Historique:
received: 15 04 2021
revised: 31 08 2021
accepted: 04 11 2021
entrez: 4 3 2022
pubmed: 5 3 2022
medline: 8 3 2022
Statut: ppublish

Résumé

To estimate the probability of onset and progression of disease and disability, length of life with or without disease and/or disability, and incidence of mortality, and to identify factors associated with transitioning to disease and/or disability over time. A prospective cohort study. Data were provided by 12,432 participants (born 1921-26) of the Australian Longitudinal Study of Women's Health linked with National Death Index data from 1996 (age: 70-75) to 2016 (age: 90-95). A five-state Markov model was fitted to estimate the transition probability, length of life with or without disease and/or disability, and the association between baseline characteristics and disease/disability/mortality risk. Over two-thirds of women had died by age 90-95, and only 3.8% of these had died with no chronic disease and disability. Those reporting chronic disease were more likely to have experienced disability (Transition Rate Ratio: 2•72, 95%CI= 2•52-2•93) than those who died without disability. At age 70-75, the expected life without chronic disease and disability was 7•68 (95%CI: 7•52-7•80) years, life with chronic disease but no disability was 4•39 (95%CI=4•23-4•49) years, and life with disability was 3.76 (95%CI=3•66-3•92) years. The factors difficulties managing on available income (HR=1•18, 95%CI=1•02-1•38), did not complete secondary school (HR=1•19, 95%CI=1•03-1•37), and overweight/obese (HR=1•36, 95%CI=1•20-1•55) were associated with an increased risk of disability. Our findings provide important insights on the onset and progression of disease and disability in older women, underscoring the importance of addressing mid-/early old-life risk factors, managing chronic conditions, and delaying disability onset and progression through targeted intervention programs.

Identifiants

pubmed: 35241234
pii: S0378-5122(21)00328-5
doi: 10.1016/j.maturitas.2021.11.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25-33

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Auteurs

Md Mijanur Rahman (MM)

Centre for Health Service Development, Building 234 |iC Enterprise 1 | Innovation Campus, University of Wollongong, NSW 2522, Australia; School of Medicine and Public Health, The University of Newcastle, Australia. Electronic address: mmrahman@uow.edu.au.

Carol Jagger (C)

Population Health Sciences Institute, Newcastle upon Tyne, Newcastle University, United Kingdom.

Emily M Princehorn (EM)

School of Medicine and Public Health, The University of Newcastle, Australia; Centre for Women's Health Research, The University of Newcastle, Australia.

Elizabeth G Holliday (EG)

School of Medicine and Public Health, The University of Newcastle, Australia.

Lucy Leigh (L)

Hunter Medical Research Institute Clinical Research Design and Statistical Services Newcastle, Australia.

Deborah J Loxton (DJ)

Centre for Women's Health Research, The University of Newcastle, Australia.

John Beard (J)

ARC Centre of Excellence in Population Ageing Research, University of New South Wales, Sydney, Australia.

Paul Kowal (P)

Centre for Women's Health Research, The University of Newcastle, Australia; World Health Organization Study on global AGEing and adult health, Geneva, Switzerland.

Julie E Byles (JE)

School of Medicine and Public Health, The University of Newcastle, Australia; Centre for Women's Health Research, The University of Newcastle, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH